Dr. Richard Isaacson was featured by ABC News following the FDA approval of the first non-antipsychotic medication for agitation associated with Alzheimer’s disease. The article explores how this new treatment offers an important option for managing one of the most challenging symptoms experienced by people living with Alzheimer’s.

Dr. Isaacson emphasized the significance of this milestone, saying:

“We’ve needed a drug like this for decades, because agitation related to Alzheimer’s disease is one of the most challenging, disheartening symptoms that we manage.”

He also reinforced that comprehensive Alzheimer’s care extends beyond medication:

“People can exercise, live a healthy lifestyle, eat a Mediterranean-style diet, and manage risk factors like blood pressure, cholesterol, and diabetes. People can really take control of their brain health, reduce their risk of Alzheimer’s and have better treatment outcomes.”

Read the full ABC News article to learn more about this important advancement in Alzheimer’s treatment.